Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence

Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas

(2017) Matthew R. Strickland et al.   JOURNAL OF NEUROSURGERY

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

(2017) Felix Sahm et al.   LANCET ONCOLOGY

Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence

(2017) Ümmügülsüm Yesilöz et al.   NEURO-ONCOLOGY

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors

(2017) Matthieu Peyre et al.   NEURO-ONCOLOGY

BAP1 mutations in high-grade meningioma: implications for patient care

(2017) Ganesh M Shankar et al.   NEURO-ONCOLOGY

Integrated genomic analyses of de novo pathways underlying atypical meningiomas

(2017) Akdes Serin Harmancı et al.   Nature Communications

Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas

(2017) Tareq A. Juratli et al.   Oncotarget

Genomic landscape of high-grade meningiomas

(2017) Wenya Linda Bi et al.   npj Genomic Medicine

Methylation-based classification of benign and malignant peripheral nerve sheath tumors

(2016) Manuel Röhrich et al.   ACTA NEUROPATHOLOGICA

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

EANO guidelines for the diagnosis and treatment of meningiomas

(2016) Roland Goldbrunner et al.   LANCET ONCOLOGY

Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival

(2016) Arjen H G Cleven et al.   MODERN PATHOLOGY

TERT Promoter Mutations and Risk of Recurrence in Meningioma

(2015) Felix Sahm et al.   JNCI-Journal of the National Cancer Institute

An Interactive Database for the Assessment of Histone Antibody Specificity

(2015) Scott B. Rothbart et al.   MOLECULAR CELL

TERT Promoter Mutations and Risk of Recurrence in Meningioma

(2015) Felix Sahm et al.   JNCI-Journal of the National Cancer Institute

Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms

(2014) David E. Reuss et al.   ACTA NEUROPATHOLOGICA

Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations

(2013) David E. Reuss et al.   ACTA NEUROPATHOLOGICA

High Incidence of ActivatingTERTPromoter Mutations in Meningiomas Undergoing Malignant Progression

(2013) Stéphane Goutagny et al.   BRAIN PATHOLOGY

Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas

(2013) Sebastian Bender et al.   CANCER CELL

Methylation markers of malignant potential in meningiomas

(2013) Jaime Vengoechea et al.   JOURNAL OF NEUROSURGERY

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations

(2013) Priscilla K Brastianos et al.   NATURE GENETICS

DNA Methylation in the Malignant Transformation of Meningiomas

(2013) Fan Gao et al.   PLoS One

Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO

(2013) V. E. Clark et al.   SCIENCE

EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer

(2012) Kyung Hyun Yoo et al.   International Journal of Biological Sciences

HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas

(2012) Angela Di Vinci et al.   Translational Research

Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses

(2011) Yugo Kishida et al.   CARCINOGENESIS

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

(2010) Brendan MacLean et al.   BIOINFORMATICS

Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

(2008) Yongkun Wei et al.   MOLECULAR CARCINOGENESIS

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

(2008) Yutaka Kondo et al.   NATURE GENETICS